IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 267 filers reported holding IVERIC BIO INC in Q2 2023. The put-call ratio across all filers is 0.39 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $132,363,364 | +308.2% | 3,364,600 | +152.5% | 0.29% | +259.3% |
| Q1 2023 | $32,425,394 | +79.6% | 1,332,733 | +58.0% | 0.08% | +65.3% |
| Q4 2022 | $18,055,289 | -40.2% | 843,311 | -49.9% | 0.05% | -47.3% |
| Q3 2022 | $30,197,000 | +524.2% | 1,683,235 | +234.7% | 0.09% | +481.2% |
| Q2 2022 | $4,838,000 | +760.9% | 502,893 | +1395.5% | 0.02% | +700.0% |
| Q4 2021 | $562,000 | – | 33,628 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Beryl Capital Management LLC | 5,339,518 | $210,056,638 | 52.85% |
| Chicago Capital Management, LLC | 359,561 | $14,145,130 | 18.12% |
| TCG Crossover Management, LLC | 2,448,829 | $96,336,933 | 15.80% |
| Vazirani Asset Management LLC | 180,000 | $7,081,200 | 11.94% |
| SYQUANT CAPITAL SAS | 406,686 | $15,999 | 11.62% |
| KRYGER CAPITAL Ltd | 2,523,853 | $99,288,377 | 10.16% |
| MPM BioImpact LLC | 1,214,662 | $47,784,803 | 9.62% |
| FNY Investment Advisers, LLC | 180,106 | $7,085 | 8.98% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 5,850,120 | $230,143,721 | 7.26% |
| HARVEST MANAGEMENT LLC | 213,500 | $8,399,090 | 7.25% |